Current medical news and unique business news for anyone who cares about the healthcare industry.
Medical residents as taxpayers. Medical residents are not students — at least as far as the IRS is concerned. In a unanimous verdict, the Supreme Court ruled against Mayo Clinic and the University of Minnesota by saying residents have to pay social security taxes. Because residents work at least 40 hours a week, they don’t fall under the tax exemption students typically receive.
The move will generate about $700 million in taxes for the government. Medical schools bemoan the lost money.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“At a time when our members are looking at reduced resources, we could have used these resources for other things, like patient care and education programs,” Ivy Baer, regulatory counsel at the Association of American Medical Colleges, told Dow Jones.
Healthcare employment and mixed messages. Mass layoffs in hospitals started to dip at the end of last year and there will be pay increases across the healthcare industry. However, the 2.6 percent pay increases predicted this year are lower than what’s forecasted in other industries, according to a survey by Hay Group.
Lilly’s so-so diabetes research alliance. A $387 million alliance between Eli Lilly and Boehringer Ingelheim will focus on developing new diabetes drugs. “I don’t think it cures what ails Lilly,” Erik Gordon, a business professor at the University of Michigan who follows the drug industry, told The New York Times. “Lilly has a real pipeline problem. They have tremendous patent fall-off. Lilly didn’t get its hands on anything that’s going to replace the revenue that disappears, and they didn’t get their hands on anything that keeps Lilly as the leader in the diabetes space.”
Janumet FDA review. Merck says the FDA is now reviewing its Type 2 diabetes pill.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Dealflow and more. Cancer drugmaker VAXIMM raised $8 million; peripheral artery disease medical device company Avinger raised $25 million and ADHD business NextWave Pharmceuticals raised $45 million.
Tribute to medical Innovation. The Council on American Medical Innovation will today webcast their summit “Medical Innovation at the Crossroads: Choosing the Path Ahead (you can watch it live online).” Whether you attend or not, you’ll likely appreciate the a video created ahead of the summit that pays tribute to medical innovation.
